First published: 30-Apr-2025 12:07:22
Staff Writer
Riyadh - Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) achieved net profits amounting to SAR 157.03 million in the first quarter (Q1) of 2025, an annual growth of 52.50% from SAR 102.97 million.
Revenues soared by 18.69% to SAR 457.53 million in Q1-25 from SAR 385.46 million in Q1-24, according to the interim financial results.
Earnings per share (EPS) recorded a jump to SAR 2.24 as of 31 March 2025 from SAR 1.47 a year earlier.
Quarterly, the Q1-25 net profits hiked by 204.26% from SAR 51.61 million in Q4-24, while the revenues increased by 76.17% from SAR 259.70 million.
The comapny's net profits reached SAR 356.52 million in 2024, up 21.93% YoY from SAR 292.40 million.
Source: Mubasher
All Rights Reserved - Mubasher Info © 2005 - 2022 Provided by SyndiGate Media Inc. (Syndigate.info).
Mubasher
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.